Dr. Taylor is leading international regenerative medicine research efforts, creating cutting edge therapies for chronic disease and “building the future treatments of tomorrow." An educator with over 25 years of teaching experience, she is truly committed to moving innovative therapies from bench to bedside, while preparing students/fellows to compete at an international level in the field of cardiac and vascular repair and regeneration. Show full bio
Dr. Doris A. Taylor has worked in the field of cardiovascular regenerative medicine since its inception and is widely regarded as a major thought-leader in the field. Her mechanistic insights and effective approaches to cardiac repair and replacement are well established and include a number of firsts.
When on the Duke University faculty, 1991-2003, she described the first functional repair of injured heart with stem cells. As director of the Center for Cardiovascular Repair at the University of Minnesota, 2003-2012, she recognized that cell therapy is unlikely to reverse end-stage organ failure; her lab began working to build organs for transplant in the laboratory. Realizing cells were available but scaffold technology lagging, her group developed a unique method to remove cells from otherwise unusable organs, leaving an intact scaffold of extracellular matrix. In 2009, she founded Miromatrix Medical Inc. to commercialize the organ perfusion decellularization/recellularization technologies developed in her lab.
Arriving at Texas Heart Institute in 2012, Dr. Taylor established both the Department of Regenerative Medicine Research and the Center for Cell and Organ Biotechnology, the latter in partnership with the Texas A&M University College of Veterinary Medicine. She also heads the Cardiovascular Cell Therapy Research Network (CCTRN) Biorepository, the cell and cytokine profiling core lab that serves multiple NIH, National Heart Lung and Blood Institute (NHLBI) networks, medical centers, and research foundations in the U.S. and Canada. She holds faculty appointments at Texas A&M and Rice University and serves as a consultant for both academic and commercial enterprises in the regenerative medicine space. She recently founded and leads a new company, Stem Cell Security, LLC, a cell banking and data management company in Houston, Texas. She has published extensively, authoring or co-authoring more than 150 scientific publications and co-editing 2 textbooks.
Dr. Taylor earned a B.S. in biology and physical sciences from Mississippi University for Women in 1977 and a Ph.D. in pharmacology from the University of Texas Southwestern Medical Center in Dallas, Texas in 1987. She holds many honors, including appointments as a Fellow of the American Heart Association and the American College of Cardiology, among others. She has been recognized by the AHA for Top 10 Research Advances. She was awarded an honorary Doctorate Science degree by her alma mater, Mississippi University for Women, in 2015 and the national Distinguished Alumnus Award presented by the American Association of State Colleges and Universities (AASCU) in 2016. She received the international Madrid Award for Excellence in Basic and Preclinical Regenerative Research in June 2017.
Dr. Taylor frequently appears as an expert on stem cell therapy and cardiac repair in the media as well as in the scientific arena. Her work has been recognized and featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, BBC Horizon, BBC News Health, ABC News, NBC News, CBS News, Associated Press, National Public Radio, NOVA Science Now, Science Channel STEM CELL UNIVERSE with Stephen Hawking, Huffington Post (Canada), and numerous other worldwide media outlets.
Texas Heart Institute Positions
- Director, Regenerative Medicine Research
- Director, Center for Cell and Organ Biotechnology at the Texas Heart Institute and Texas A&M University
- Editorial Board, Texas Heart Institute Journal
- Cardiovascular Cell Therapy Research Network (CCTRN), NIH National Heart, Lung, and Blood Institute
- Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine (CTSN), NIH National Heart, Lung, and Blood Institute
- Center for Cell and Organ Biotechnology, Texas Emerging Technology Fund
- Sex Differences in Bone Marrow Proteome among Cardiovascular Patients, Alpha Phi Foundation
- NASA - Vascular Health in Space: MicroRNAs in Microgravity
- Regenerative medicine
- Cell and gene therapy for treatment of cardiovascular disease
- Sex differences in cardiac and vascular cell-based therapies
- Tissue engineering of whole organs and cardiac patches
- Cell-based prevention of disease
- Aging as a failure of stem cells
- Complementary and alternative approaches to endogenous (cell-mediated) repair
Mississippi University for Women (biology and physical sciences)
University of Texas Southwestern Medical Center (pharmacology)
Albert Einstein College of Medicine (immunology)
Academic & Clinical Affiliations
- Texas A&M University College of Veterinary Medicine and Biomedical Sciences, Department of Veterinary Physiology and Pharmacology
- Rice University Weiss School of Natural Sciences, Department of Biosciences
- Gulf Coast Consortia for Quantitative Biomedical Sciences
Honors, Awards and Memberships
- Fellow, European Society of Cardiology.
- 4th Madrid Award for Excellence in Basic and Preclinical Cardiovascular Regenerative Research (2017)
- Distinguished Alumnus Award, American Association of State Colleges and Universities (AASCU) (2016)
- Distinguished Alumnae Achievement Award, Mississippi University for Women Alumni Association (2016)
- BioHouston Women in Science with Excellence (WISE) Award, Houston Chronicle Special Section (2016)
- Honorary Doctorate of Science, Mississippi University for Women, Columbus, Mississippi (2015)
- Honoree, Hearts of Gold Gala Honoring Women in Health and Medical Science, John P. McGovern Museum of Health & Medical Science, Houston, TX (2014)
- Honorary Professorship, Kuban State Medical University, Krasnodar, Russia (2013)
- Fellow, American College of Cardiology (2011)
- Fellow, AHA Council on Functional Genomics and Translational Biology (2011)
- Fellow, American Heart Association and the Council on Basic Cardiovascular Sciences (2010)
- U.S. Food and Drug Administration Advisory Council Service Award (2010)
- Schwarzenegger Scientific Award for the Advancement of Cardiovascular Research. International Society for Cardiovascular Translational Research (2009)
- Top Health Story of 2008, CNN (2008)
- Grand Award for Health Discoveries, Popular Science (2008)
- Top Images of 2008, Nature Medicine (2008)
- Top 10 Research Advances of 2008, American Heart Association (2008)
- Alumnae Achievement Award, Mississippi University for Women Alumni Association (2000)
Texas Heart Institute has been at the forefront of cardiovascular discovery and innovation since its formation. It continues to relentlessly...
Texas Heart Institute director of Regenerative Medicine Research and director of the Center for Cell and Organ Biotechnology, Dr. Doris A....
The American Heart Association Scientific Sessions were held in Philadelphia, Pennsylvania November 16-18 to showcase the latest cutting-edge science and education...